Exponent Inc (EXPO) Stock Price
EXPOStock
$71.85+5.27%52W
Market Cap$3.42B
P/E32.23x
PEG Ratio2.03
Div yield1.34%
Beta0.71
EXPO Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-3.54%
Price vs S&P 500 (4W)8.37%
PEG Ratio2.03
VGM Score46.25
P/E Ratio (Annual)32.23x
Indicated Dividend Yield (Annual)1.34%
EXPO Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | $0.60 | $0.60 | +0.43%(+$0.00) | |
| Q1 2026 | $0.61 | $0.59 | -3.18%(-$0.02) | |
| Q4 2025 | $0.47 | $0.49 | +3.55%(+$0.02) | |
| Q3 2025 | $0.53 | $0.55 | +3.74%(+$0.02) | |
| Q2 2025 | $0.52 | $0.52 | +0.78%(+$0.00) |
EXPO Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
4.10
4.10
4.10
4.10
Industry Peers — Management Consulting(39)
| Symbol | Value Score | Growth Score | Momentum Score | P/E Ratio (Annual) | ROE (TTM) | Revenue Growth (5Y) | Indicated Dividend Yield (Annual) | Price |
|---|---|---|---|---|---|---|---|---|
EXPOExponent Inc | D | C | B | 32.2x | 27.9% | 7.8% | 1.3% | $71.85 |
| GIBCGI Inc. | B | C | B | 13.1x | 17.2% | 5.5% | 0.7% | $75.30 |
| BAHBooz Allen Hamilton Holding Corporation | B | D | C | 10.5x | 71.9% | 7.4% | 1.5% | $74.26 |
| GGENPACT LIMITED | B | C | B | 11.3x | 22.9% | 6.5% | 1.6% | $37.26 |
| FCNFTI Consulting, Inc. | B | D | C | 15.1x | 15.6% | 9.0% | — | $148.53 |
| HURNHuron Consulting Group Inc. | C | B | A | 26.5x | 25.5% | 14.3% | — | $174.86 |
| ASTHAstrana Health Inc. Common Stock | C | B | C | 81.2x | 5.1% | 35.9% | — | $36.81 |
| ICFIICF International, Inc. | B | D | B | 17.5x | 8.6% | 4.4% | 0.4% | $89.43 |
| BWMNBowman Consulting Group Ltd. Common Stock | D | B | B | 57.7x | 2.9% | 32.1% | — | $42.77 |
| ROMARoma Green Finance Limited Class A Ordinary Shares | F | B | B | — | -67.9% | — | — | $8.34 |
| ONTOnterris, Inc. | C | C | C | — | -2.5% | 20.4% | — | $14.01 |
About Exponent Inc
Exponent Inc provides specialized engineering and scientific consulting services to address complex problems across multiple industries. The company operates two segments: Engineering and Science (majority of revenue), encompassing biomechanics, biomedical, civil, and construction consulting; and Environmental and Health, covering chemical regulation, food safety, and ecological sciences. Its team comprises scientists, engineers, physicians, and regulatory specialists. The firm generates substantially all revenue from the United States.